Silver Book Fact

A one percent reduction in cancer-related deaths in the U.S. would be worth an estimated $500 billion to society from increased quality of life and increased productivity from longer lives.

Murphy, K and R Topel. The Value of Health and Longevity. J Political Econ. 2006; 114(5): 871-904. https://www.dartmouth.edu/~jskinner/documents/MurphyTopelJPE.pdf

Reference

Title
The Value of Health and Longevity
Publication
J Political Econ
Publication Date
2006
Authors
Murphy, K and R Topel
Volume & Issue
Volume 114, Issue 5
Pages
871-904
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • Cancer Survivors in the United States  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • Death rates from breast cancer have steadily decreased in women since 1990. This decrease represents progress in both early detection and improved treatment.  
  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.